Literature DB >> 18953446

Clarifying the role of salvage radiotherapy.

Joseph Chin1.   

Abstract

Year:  2008        PMID： 18953446      PMCID： PMC2572242          DOI： 10.5489/cuaj.917

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  7 in total

1.  Salvage radiotherapy following biochemical relapse after radical prostatectomy: proceedings of the Genito-Urinary Radiation Oncologists of Canada consensus meeting.

Authors:  Michael Sia; Tom Pickles; Gerard Morton; Louis Souhami; Himu Lukka; Padraig Warde
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

2.  111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group.

Authors:  D Kahn; R D Williams; M J Manyak; M K Haseman; D W Seldin; J A Libertino; R T Maguire
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

3.  Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911).

Authors:  Michel Bolla; Hein van Poppel; Laurence Collette; Paul van Cangh; Kris Vekemans; Luigi Da Pozzo; Theo M de Reijke; Antony Verbaeys; Jean-François Bosset; Roland van Velthoven; Jean-Marie Maréchal; Pierre Scalliet; Karin Haustermans; Marianne Piérart
Journal:  Lancet       Date:  2005 Aug 13-19       Impact factor: 79.321

4.  Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.

Authors:  Ian M Thompson; Catherine M Tangen; Jorge Paradelo; M Scott Lucia; Gary Miller; Dean Troyer; Edward Messing; Jeffrey Forman; Joseph Chin; Gregory Swanson; Edith Canby-Hagino; E David Crawford
Journal:  JAMA       Date:  2006-11-15       Impact factor: 56.272

5.  Single photon emission computerized tomography with capromab pendetide plus computerized tomography image set co-registration independently predicts biochemical failure.

Authors:  R J Ellis; E H Zhou; P Fu; D A Kaminsky; D B Sodee; P F Faulhaber; D Bodner; M I Resnick
Journal:  J Urol       Date:  2008-03-17       Impact factor: 7.450

6.  Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

Authors:  Andrew J Stephenson; Peter T Scardino; Michael W Kattan; Thomas M Pisansky; Kevin M Slawin; Eric A Klein; Mitchell S Anscher; Jeff M Michalski; Howard M Sandler; Daniel W Lin; Jeffrey D Forman; Michael J Zelefsky; Larry L Kestin; Claus G Roehrborn; Charles N Catton; Theodore L DeWeese; Stanley L Liauw; Richard K Valicenti; Deborah A Kuban; Alan Pollack
Journal:  J Clin Oncol       Date:  2007-05-20       Impact factor: 44.544

7.  Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.

Authors:  Andrew J Stephenson; Shahrokh F Shariat; Michael J Zelefsky; Michael W Kattan; E Brian Butler; Bin S Teh; Eric A Klein; Patrick A Kupelian; Claus G Roehrborn; David A Pistenmaa; Heather D Pacholke; Stanley L Liauw; Matthew S Katz; Steven A Leibel; Peter T Scardino; Kevin M Slawin
Journal:  JAMA       Date:  2004-03-17       Impact factor: 56.272
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.